Latest News - Ora

Wednesday, March 22, 2017 | Glaucoma, Partnerships, Ora

AXIM Biotech Retains ORA to Manage Glaucoma & Dry Eye Indications Product Development and Clinical Trials

Axim Biotechnologies is retaining the services from contract research organization Ora to run the company’s upcoming product development and clinical trials for the treatment of glaucoma and dry…

Read the full story